Immuneering Corp. (IMRX)
4.98
-0.19
(-3.68%)
USD |
NASDAQ |
Mar 05, 16:00
4.97
-0.01
(-0.20%)
After-Hours: 20:00
Immuneering Cash from Investing (Quarterly) : -0.0073M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 44.87M |
| Verastem, Inc. | -- |
| Phathom Pharmaceuticals, Inc. | -0.087M |
| Tango Therapeutics, Inc. | 47.48M |
| Moderna, Inc. | -48.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.98M |
| Cash from Financing (Quarterly) | 213.19M |
| Free Cash Flow | -50.04M |
| Free Cash Flow Per Share (Quarterly) | -0.3021 |
| Free Cash Flow to Equity (Quarterly) | -11.90M |
| Free Cash Flow to Firm (Quarterly) | -11.98M |
| Free Cash Flow Yield | -28.26% |